Reversed-phase HPLC (RP-HPLC) remains the gold standard for peptide purification, providing the resolution needed to separate target peptides from closely related impurities. The global CDMO Service for Peptide APIs market is projected to grow to US$ 13,186 million by 2032[reference:144], driving demand for efficient purification methods.
RP-HPLC for peptide purification typically uses C18 or C8 stationary phases with aqueous/organic mobile phases. The separation is based on hydrophobic interactions between the peptide and the stationary phase, with more hydrophobic peptides eluting later in the gradient. Key factors in method development include stationary phase selection, mobile phase composition, gradient optimization, and flow rate.
Stationary phase selection is critical for achieving the desired separation. C18 phases provide the highest retention and are suitable for most peptides. C8 phases provide less retention and may be preferred for very hydrophobic peptides. Specialized phases are available for specific applications, including peptides with unusual properties.
Gradient optimization is essential for achieving high resolution. The gradient should be shallow enough to separate closely related impurities but steep enough to maintain reasonable run times. The starting and ending mobile phase compositions should be optimized for the specific peptide. Temperature control can also improve resolution and reproducibility.
Preparative HPLC for peptide purification requires consideration of column loading, flow rate, and detection. Overloading the column reduces resolution, while underloading reduces productivity. Flow rate affects both resolution and run time. Detection must be sensitive enough to monitor the target peptide and impurities. At PeptideHub, we optimize purification protocols for each peptide to achieve target purity with high recovery.